Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
已确立的β-淀粉样蛋白病理不受选择性5-羟色胺再摄取抑制剂帕罗西汀长期治疗的影响。
期刊:Alzheimer's and Dementia: Translational Research and Clinical Interventions
影响因子:
doi:10.1016/j.trci.2018.04.005
Severino, Maurizio; Sivasaravanaparan, Mithula; Olesen, Louise Ø; von Linstow, Christian U; Metaxas, Athanasios; Bouzinova, Elena V; Khan, Asif Manzoor; Lambertsen, Kate L; Babcock, Alicia A; Gramsbergen, Jan Bert; Wiborg, Ove; Finsen, Bente